{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T14:45:15Z","timestamp":1784126715183,"version":"3.55.0"},"update-to":[{"DOI":"10.1002\/14651858.cd005951.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T00:00:00Z","timestamp":1698019200000}}],"reference-count":97,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd005951.pub5","type":"journal-article","created":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T06:52:18Z","timestamp":1698043938000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Haemostatic therapies for stroke due to acute, spontaneous intracerebral haemorrhage"],"prefix":"10.1002","volume":"2023","author":[{"given":"Helle","family":"Eilertsen","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine; Oslo University Hospital; Oslo Norway"},{"name":"Faculty of Medicine, Institute of Clinical Medicine; University of Oslo; Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaamanti S","family":"Menon","sequence":"additional","affiliation":[{"name":"Stroke Medicine; University of Nottingham; Nottingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe Kang","family":"Law","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Medicine; Universiti Kebangsaan Malaysia Medical Centre; Kuala Lumpur Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[{"name":"The George Institute for Global Health; Faculty of Medicine, UNSW; Sydney Australia"},{"name":"The George Institute for Global Health; Beijing China"},{"name":"Department of Neurology; Shanghai East Hospital, School of Medicine, Tongji University; Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip M","family":"Bath","sequence":"additional","affiliation":[{"name":"Stroke Medicine; University of Nottingham; Nottingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Steiner","sequence":"additional","affiliation":[{"name":"Klinikum Frankfurt H\u00f6chst; Frankfurt Germany"},{"name":"Department of Neurology; Heidelberg University Hospital; Heidelberg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael JR","family":"Desborough","sequence":"additional","affiliation":[{"name":"Department of Clinical Haematology; Oxford University Hospitals NHS Foundation Trust; Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Else C","family":"Sandset","sequence":"additional","affiliation":[{"name":"Department of Neurology; Oslo University Hospital Ullev\u00e5l; Oslo Norway"},{"name":"The Norwegian Air Ambulance Foundation; Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikola","family":"Sprigg","sequence":"additional","affiliation":[{"name":"Stroke Medicine; University of Nottingham; Nottingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rustam","family":"Al-Shahi Salman","sequence":"additional","affiliation":[{"name":"Centre for Clinical Brain Sciences; University of Edinburgh; Edinburgh UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,10,23]]},"reference":[{"issue":"Special Issue","key":"10.1002\/14651858.CD005951.pub5-BIB0001|cit1","first-page":"62","article-title":"Tranexamic acid as antifibrinolytic agent in non traumatic intracerebral hemorrhages","volume":"22","author":"Arumugam","year":"2015","journal-title":"Malaysian Journal of Medical Sciences"},{"issue":"16","key":"10.1002\/14651858.CD005951.pub5-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1182\/blood.2019003298","article-title":"PATCH trial: explanatory analyses","volume":"135","author":"Baharoglu","year":"2020","journal-title":"Blood"},{"issue":"10038","key":"10.1002\/14651858.CD005951.pub5-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1016\/S0140-6736(16)30392-0","article-title":"Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial","volume":"387","author":"Baharoglu","year":"2016","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2377-10-19","article-title":"PATCH: platelet transfusion in cerebral haemorrhage: study protocol for a multicentre, randomised, controlled trial","volume":"10","author":"Gans","year":"2010","journal-title":"BMC Neurology"},{"issue":"5","key":"10.1002\/14651858.CD005951.pub5-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1097\/00006123-199911000-00020","article-title":"Use of factor IX complex in warfarin-related intracranial hemorrhage","volume":"45","author":"Boulis","year":"1999","journal-title":"Neurosurgery"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0006|cit6","unstructured":"Randomised, double-blind, multicentre, placebo controlled dose-escalation study to evaluate the safety and preliminary efficacy of activated recombinant factor VII (NN-007) in acute intracerebral haemorrhage Unpublished 2007"},{"issue":"12","key":"10.1002\/14651858.CD005951.pub5-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1001\/jamaneurol.2019.2636","article-title":"Effect of recombinant activated coagulation factor VII on hemorrhage expansion among patients with spot sign-positive acute intracerebral hemorrhage: the SPOTLIGHT and STOP-IT randomized clinical trials","volume":"76","author":"Gladstone","year":"2019","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0008|cit8","unstructured":"The Spot Sign for predicting and treating ICH growth study (STOP-IT) clinicaltrials.gov\/ct2\/show\/NCT00810888"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0009|cit9","unstructured":"'Spot Sign' selection of intracerebral hemorrhage to guide hemostatic therapy (SPOTLIGHT) clinicaltrials.gov\/ct2\/show\/NCT01359202"},{"issue":"2","key":"10.1002\/14651858.CD005951.pub5-BIB0010|cit10","first-page":"168","article-title":"Intraoperative intravenous administration of rFVIIa and hematoma volume after early surgery for spontaneous intracerebral hemorrhage: a randomized prospective phase II study","volume":"78","author":"Imberti","year":"2012","journal-title":"Minerva Anestesiologica"},{"issue":"2","key":"10.1002\/14651858.CD005951.pub5-BIB0011|cit11","first-page":"161","article-title":"Intervention study on recombinant activated factor VIIa in depressing early hematoma extensions of cerebral hemorrhage","volume":"21","author":"Li","year":"2012","journal-title":"Chinese Journal of New Drugs"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1136\/svn-2021-000942","article-title":"Tranexamic acid for acute intracerebral haemorrhage growth based on imaging assessment (TRAIGE): a multicentre, randomised, placebo-controlled trial","volume":"6","author":"Liu","year":"2021","journal-title":"Stroke & Vascular Neurology"},{"issue":"3","key":"10.1002\/14651858.CD005951.pub5-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1177\/1747493017694394","article-title":"Tranexamic acid for acute intracerebral hemorrhage growth predicted by spot sign trial: rationale and design","volume":"12","author":"Liu","year":"2017","journal-title":"International Journal of Stroke"},{"issue":"1","key":"10.1002\/14651858.CD005951.pub5-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1161\/01.STR.0000149628.80251.b8","article-title":"Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage","volume":"36","author":"Mayer","year":"2005","journal-title":"Stroke"},{"issue":"8","key":"10.1002\/14651858.CD005951.pub5-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa042991","article-title":"Recombinant activated factor VII for acute intracerebral hemorrhage","volume":"352","author":"Mayer","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD005951.pub5-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1385\/NCC:4:3:206","article-title":"Recombinant activated factor VII for acute intracerebral hemorrhage: US phase IIA trial","volume":"4","author":"Mayer","year":"2006","journal-title":"Neurocritical Care"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0017|cit17","doi-asserted-by":"crossref","unstructured":"Mayer SA Brun NC Begtrup K Broderick J Davis S Diringer MN Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage New England Journal of Medicine 2008 358 20 2127 37","DOI":"10.1056\/NEJMoa0707534"},{"issue":"4","key":"10.1002\/14651858.CD005951.pub5-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/ijs.12132","article-title":"The Spot sign and Tranexamic acid On Preventing ICH growth \u2013 AUStralasia Trial (STOP-AUST): protocol of a phase II randomized, placebo-controlled, double-blind, multicenter trial","volume":"9","author":"Meretoja","year":"2014","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S1474-4422(20)30369-0","article-title":"Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trial","volume":"19","author":"Meretoja","year":"2020","journal-title":"Lancet Neurology"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3760\/cma.j.issn.1673-4165.2020.04.005","article-title":"Tranexamic acid for spontaneous intracerebral hemorrhage: a randomized controlled study","volume":"12","author":"Ni","year":"2020","journal-title":"International Journal of Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0021|cit21","unstructured":"Treatment of intracerebral hemorrhage in patients on non-vitamin K antagonist (TICH-NOAC) clinicaltrials.gov\/ct2\/show\/NCT02866838"},{"issue":"9","key":"10.1002\/14651858.CD005951.pub5-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1161\/STROKEAHA.123.042866","article-title":"Tranexamic acid for intracerebral hemorrhage in patients on non-vitamin K antagonist oral anticoagulants (TICH-NOAC): a multicenter, randomized, placebo-controlled, phase 2 trial","volume":"54","author":"Polymeris","year":"2023","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0023|cit23","first-page":"7","article-title":"Tranexamic acid for acute intracerebral haemorrhage (TICH): results of the first randomised controlled trial","volume":"7","author":"Sprigg","year":"2012","journal-title":"International Journal of Stroke"},{"issue":"6","key":"10.1002\/14651858.CD005951.pub5-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.11.007","article-title":"Tranexamic acid for spontaneous intracerebral hemorrhage: a randomized controlled pilot trial","volume":"23","author":"Sprigg","year":"2014","journal-title":"Journal of Stroke and Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"e019930","DOI":"10.1136\/bmjopen-2017-019930","article-title":"Does tranexamic acid lead to changes in MRI measures of brain tissue health in patients with spontaneous intracerebral haemorrhage?","volume":"8","author":"Dineen","year":"2018","journal-title":"BMJ Open"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1186\/s13063-017-2341-5","article-title":"Statistical analysis plan for the 'Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage' (TICH-2) trial","volume":"18","author":"Flaherty","year":"2017","journal-title":"Trials"},{"issue":"5","key":"10.1002\/14651858.CD005951.pub5-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"e019130","DOI":"10.1161\/JAHA.120.019130","article-title":"Outcomes in antiplatelet-associated intracerebral hemorrhage in the TICH-2 randomized controlled trial","volume":"10","author":"Law","year":"2021","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s12975-020-00845-6","article-title":"Predictors and outcomes of neurological deterioration in intracerebral hemorrhage: results from the TICH-2 randomized controlled trial","volume":"12","author":"Law","year":"2021","journal-title":"Translational Stroke Research"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1161\/STROKEAHA.120.032426","article-title":"Tranexamic acid for prevention of hematoma expansion in intracerebral hemorrhage patients with or without spot sign","volume":"52","author":"Ovesen","year":"2021","journal-title":"Stroke"},{"issue":"5","key":"10.1002\/14651858.CD005951.pub5-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1001\/jamaneurol.2022.0217","article-title":"Effect of tranexamic acid administration on remote cerebral ischemic lesions in acute spontaneous intracerebral hemorrhage: a substudy of a randomized clinical trial","volume":"79","author":"Pszczolkowski","year":"2022","journal-title":"JAMA Neurology"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/S0140-6736(18)31033-X","article-title":"Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial","volume":"391","author":"Sprigg","year":"2018","journal-title":"Lancet"},{"issue":"35","key":"10.1002\/14651858.CD005951.pub5-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta23350","article-title":"Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCT","volume":"23","author":"Sprigg","year":"2019","journal-title":"Health Technology Assessment"},{"issue":"6","key":"10.1002\/14651858.CD005951.pub5-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1177\/1747493016641960","article-title":"Intravenous tranexamic acid for hyperacute primary intracerebral hemorrhage: protocol for a randomized, placebo-controlled trial","volume":"11","author":"Sprigg","year":"2016","journal-title":"International Journal of Stroke"},{"issue":"6","key":"10.1002\/14651858.CD005951.pub5-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S1474-4422(16)00110-1","article-title":"Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial","volume":"15","author":"Steiner","year":"2016","journal-title":"Lancet Neurology"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0035|cit35","unstructured":"Zazulia AR Antifibrinolytic therapy in acute intracerebral hemorrhage \u2013 ATICH www.strokecenter.org"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0036|cit36","unstructured":"Ciccone A Brambilla G Pozzi M Roccatagliata D Botto E Gruccione A Antifibrinolytic treatment of acute spontaneous intracerebral haemorrhage: rationale of the ANTITHESIS protocol Italian Stroke Forum; 2007; Florence (Italy) 2007"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0037|cit37","unstructured":"The Norwegian Intracerebral Hemorrhage Trial (NOR-ICH) helseforskning.etikkom.no\/prosjekterirek\/prosjektregister\/prosjekt?p_document_id=324797"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"R4","DOI":"10.1186\/cc11923","article-title":"A French multicenter randomised trial comparing two dose-regimens of prothrombin complex concentrates in urgent anticoagulation reversal","volume":"17","author":"Kerebel","year":"2013","journal-title":"Critical Care"},{"issue":"5","key":"10.1002\/14651858.CD005951.pub5-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s11655-016-2467-7","article-title":"Activating blood circulation to remove stasis treatment of hypertensive intracerebral hemorrhage: a multi-center prospective randomized open-label blinded-endpoint trial","volume":"22","author":"Zhou","year":"2016","journal-title":"Chinese Journal of Integrative Medicine"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD005951.pub5-BIB0040|cit40","first-page":"158","article-title":"Effect of Novoseven on hospitalization duration of Iranian ICH patients","volume":"25","author":"Madjdinasab","year":"2008","journal-title":"Cerebrovascular Diseases"},{"issue":"3","key":"10.1002\/14651858.CD005951.pub5-BIB0041|cit41","first-page":"233","article-title":"Auxiliary treatment of aprotinin on cerebral hemorrhage: clinical observation","volume":"20","author":"Meng","year":"2003","journal-title":"Journal of Apoplexy and Nervous Diseases"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0042|cit42","unstructured":"rFVIIa in ICH in patients treated with anticoagulants or anti-platelets clinicaltrials.gov\/ct2\/show\/NCT00222625"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0043|cit43","unstructured":"FFP versus PCC in intracranial hemorrhage clinicaltrials.gov\/ct2\/show\/NCT02429453"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0044|cit44","unstructured":"Vitamin K1 in the treatment of spontaneous intracerebral hemorrhage clinicaltrials.gov\/ct2\/show\/NCT03388970"},{"issue":"1","key":"10.1002\/14651858.CD005951.pub5-BIB0045|cit45","first-page":"22","article-title":"Mechanism of aprotinin in auxiliary treatment of cerebral hemorrhage","volume":"38","author":"Zhou","year":"2005","journal-title":"Chinese Journal of Neurology"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0046|cit46","unstructured":"A randomized clinical trial of andexanet alfa in acute intracranial hemorrhage in patients receiving an oral factor XA inhibitor clinicaltrialsregister.eu\/ctr-search\/trial\/2018-002620-17"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"e037555","DOI":"10.1136\/bmjopen-2020-037555","article-title":"Desmopressin for reversal of Antiplatelet drugs in Stroke due to Haemorrhage (DASH): protocol for a phase II double-blind randomised controlled feasibility trial","volume":"10","author":"Desborough","year":"2020","journal-title":"BMJ Open"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0048|cit48","unstructured":"Effect of tranexamic acid on mortality and morbidity in spontaneously ICH patients irct.ir\/trial\/43431"},{"issue":"10","key":"10.1002\/14651858.CD005951.pub5-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"105136","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105136","article-title":"Rationale and design of a randomized, double-blind trial evaluating the efficacy of tranexamic acid on hematoma expansion and peri-hematomal edema in patients with spontaneous intracerebral hemorrhage within 4.5 h after symptom onset: the THE-ICH trial protocol","volume":"29","author":"Jiang","year":"2020","journal-title":"Journal of Stroke and Cerebrovascular Diseases"},{"issue":"7","key":"10.1002\/14651858.CD005951.pub5-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1177\/17474930211042700","article-title":"Recombinant factor VIIa for hemorrhagic stroke treatment at earliest possible time (FASTEST): protocol for a phase III, double-blind, randomized, placebo-controlled trial","volume":"17","author":"Naidech","year":"2022","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0051|cit51","unstructured":"Platelet transfusion in acute intracerebral hemorrhage clinicaltrials.gov\/ct2\/show\/NCT00699621"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0052|cit52","unstructured":"Prothrombin complex concentrate versus fresh frozen plasma to correct coagulation disorders in adult neurosurgical patients (CLOT-CRANE) clinicaltrials.gov\/ct2\/show\/NCT02777424"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0053|cit53","unstructured":"Tranexamic acid for spontaneous acute cerebral hemorrhage trial (TRANSACT) clinicaltrials.gov\/ct2\/show\/NCT03044184"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0054|cit54","unstructured":"Effectiveness of intravenous tranexamic acid in primary cerebral hemorrhage for prevention of hematoma progression: protocol for a randomized, double blind placebo-controlled trial clinicaltrials.gov\/study\/NCT04742205"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0055|cit55","unstructured":"Indian trial of tranexamic acid in spontaneous intracerebral haemorrhage clinicaltrials.gov\/study\/NCT05836831"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0056|cit56","unstructured":"Efficacy and safety of tranexamic acid for hyperacute intracerebral hemorrhage treatment: a multi-center randomized controlled trial \u2013 TARGET www.chictr.org.cn\/showprojEN.html?proj=124135"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0057|cit57","unstructured":"Tranexamic acid for very early bleeds in the brain www.isrctn.com\/ISRCTN97695350"},{"issue":"2","key":"10.1002\/14651858.CD005951.pub5-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1136\/svn-2021-001070","article-title":"Tranexamic acid for intracerebral haemorrhage within 2 hours of onset: protocol of a phase II randomised placebo-controlled double-blind multicentre trial","volume":"7","author":"Yassi","year":"2022","journal-title":"Stroke and Vascular Neurology"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"b2586","DOI":"10.1136\/bmj.b2586","article-title":"Spontaneous intracerebral haemorrhage","volume":"339","author":"Al-Shahi Salman","year":"2009","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD005951.pub5-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1474-4422(09)70340-0","article-title":"Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis","volume":"9","author":"Asch","year":"2010","journal-title":"Lancet Neurology"},{"issue":"4","key":"10.1002\/14651858.CD005951.pub5-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1177\/2396987319849763","article-title":"European Stroke Organisation Guideline on reversal of oral anticoagulants in acute intracerebral haemorrhage","volume":"4","author":"Christensen","year":"2019","journal-title":"European Stroke Journal"},{"issue":"12","key":"10.1002\/14651858.CD005951.pub5-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1182\/blood-2013-04-497123","article-title":"The effect of desmopressin on platelet function: a selective enhancement of procoagulant COAT platelets in patients with primary platelet function defects","volume":"123","author":"Colucci","year":"2014","journal-title":"Blood"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0063|cit63","unstructured":"Covidence Veritas Health Innovation 2022"},{"issue":"8","key":"10.1002\/14651858.CD005951.pub5-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1212\/01.wnl.0000208408.98482.99","article-title":"Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage","volume":"66","author":"Davis","year":"2006","journal-title":"Neurology"},{"issue":"9913","key":"10.1002\/14651858.CD005951.pub5-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0140-6736(13)61953-4","article-title":"Global and regional burden of stroke during 1990\u20132010: findings from the Global Burden of Disease study 2010","volume":"383","author":"Feigin","year":"2013","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD005951.pub5-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000441085","article-title":"Update on the global burden of ischemic and hemorrhagic stroke in 1990\u20132013: the GBD 2013 Study","volume":"45","author":"Feigin","year":"2015","journal-title":"Neuroepidemiology"},{"issue":"1","key":"10.1002\/14651858.CD005951.pub5-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1186\/s13063-017-2341-5","article-title":"Statistical analysis plan for the 'Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage' (TICH-2) trial","volume":"18","author":"Flaherty","year":"2017","journal-title":"Trials"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0068|cit68","first-page":"795","article-title":"Global, regional, and national burden of stroke and its risk factors, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"20","author":"GBD 2019 Stroke Collaborators","journal-title":"Lancet Neurology"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0069|cit69","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Oxman A Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013 Available from gdt.gradepro.org\/app\/handbook\/handbook.html"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0070|cit70","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime) 2022"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0071|cit71","doi-asserted-by":"publisher","first-page":"e282","DOI":"10.1161\/STR.0000000000000407","article-title":"2022 guideline for the management of patients with spontaneous intracerebral hemorrhage: a guideline from the American Heart Association\/American Stroke Association","volume":"53","author":"Greenberg","year":"2022","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0072|cit72","doi-asserted-by":"publisher","first-page":"761185","DOI":"10.3389\/fneur.2021.761185","article-title":"Tranexamic acid for acute spontaneous intracerebral haemorrhage: a meta-analysis of randomized controlled trials","volume":"12","author":"Guo","year":"2021","journal-title":"Frontiers in Neurology"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0073|cit73","unstructured":"Higgins JP Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S1474-4422(18)30253-9","article-title":"Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data","volume":"17","author":"ICH Growth Individual Patient Data Meta-analysis Collaborators","year":"2018","journal-title":"Lancet Neurology"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0075|cit75","unstructured":"rFVIIa in ICH in patients treated with anticoagulants or anti-platelets [personal communication] Email to: A Iorio"},{"issue":"4","key":"10.1002\/14651858.CD005951.pub5-BIB0076|cit76","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/S1474-4422(22)00044-8","article-title":"Research priorities to improve stroke outcomes","volume":"21","author":"Hill","year":"2022","journal-title":"Lancet Neurology"},{"issue":"7","key":"10.1002\/14651858.CD005951.pub5-BIB0077|cit77","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010555.pub2","article-title":"Prothrombin complex concentrate for reversal of vitamin K antagonist treatment in bleeding and non-bleeding patients","author":"Johansen","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD005951.pub5-BIB0078|cit78","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004896.pub4","article-title":"Antifibrinolytic drugs for acute traumatic injury","author":"Ker","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD005951.pub5-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1161\/STROKEAHA.109.575043","article-title":"Stroke incidence is decreasing in whites but not in blacks: a population-based estimate of temporal trends in stroke incidence from the Greater Cincinnati\/Northern Kentucky Stroke Study","volume":"41","author":"Kleindorfer","year":"2010","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0080|cit80","unstructured":"Lefebvre C Glanville J Briscoe S Featherstone R Littlewood A Marshall C Technical supplement to Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston MS, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook\/archive\/v6.3"},{"issue":"6","key":"10.1002\/14651858.CD005951.pub5-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1474-4422(07)70107-2","article-title":"Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based study","volume":"6","author":"Lovelock","year":"2007","journal-title":"Lancet Neurology"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0082|cit82","unstructured":"Mayer SA The FAST Trial 16th European Stroke Conference; 2007 May 29-June 1, 2007; Glasgow (UK) 2007"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0083|cit83","unstructured":"National Institute for Health and Care Excellence (NICE) Stroke and transient ischaemic attack in over 16s: diagnosis and initial management. NICE guideline (NG128); May 2019 Available at www.nice.org.uk\/guidance\/ng128 31211538"},{"issue":"6","key":"10.1002\/14651858.CD005951.pub5-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1136\/jnnp-2013-306476","article-title":"Long-term prognosis after intracerebral haemorrhage: systematic review and meta-analysis","volume":"85","author":"Poon","year":"2014","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0085|cit85","volume-title":"National Clinical Guideline for Stroke","author":"Intercollegiate Stroke Working Party","year":"2016"},{"issue":"3","key":"10.1002\/14651858.CD005951.pub5-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1161\/STROKEAHA.114.007953","article-title":"Influence of intracerebral hemorrhage location on incidence, characteristics, and outcome: population-based study","volume":"46","author":"Samarasekera","year":"2015","journal-title":"Stroke"},{"issue":"2","key":"10.1002\/14651858.CD005951.pub5-BIB0087|cit87","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/ana.25732","article-title":"Neurosurgical intervention for supratentorial intracerebral hemorrhage","volume":"88","author":"Sondag","year":"2020","journal-title":"Annals of Neurology"},{"issue":"2","key":"10.1002\/14651858.CD005951.pub5-BIB0088|cit88","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005011.pub4","article-title":"Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia","author":"Simpson","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD005951.pub5-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/ijs.12309","article-title":"European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage","volume":"9","author":"Steiner","year":"2014","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0090|cit90","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1007\/s40263-021-00865-2","article-title":"Tranexamic acid for adult patients with spontaneous intracerebral hemorrhage: a systematic review with meta-analysis","volume":"35","author":"Wang","year":"2021","journal-title":"CNS Drugs"},{"issue":"8","key":"10.1002\/14651858.CD005951.pub5-BIB0091|cit91","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008864.pub2","article-title":"Fibrinogen concentrate in bleeding patients","author":"Wikkels\u00f8","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD005951.pub5-BIB0092|cit92","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1080\/00207454.2021.1953020","article-title":"Tranexamic acid in intracerebral hemorrhage: a meta-analysis","volume":"133","author":"Yu","year":"2023","journal-title":"International Journal of Neuroscience"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0093|cit93","unstructured":"ATICH [personal communication] Email to: A Zazulia"},{"key":"10.1002\/14651858.CD005951.pub5-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1161\/01.STR.0000251797.86897.a3","article-title":"Hemostatic drug therapies for acute, nontraumatic intracerebral hemorrhage","volume":"38","author":"Al-Shahi","year":"2007","journal-title":"Stroke"},{"issue":"4","key":"10.1002\/14651858.CD005951.pub5-BIB0095|cit95","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005951.pub3","article-title":"Haemostatic drug therapies for acute spontaneous intracerebral haemorrhage","author":"Al-Shahi Salman","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD005951.pub5-BIB0096|cit96","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005951.pub4","article-title":"Haemostatic therapies for acute spontaneous intracerebral haemorrhage","author":"Al-Shahi Salman","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD005951.pub5-BIB0097|cit97","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005951.pub2","article-title":"Haemostatic drug therapies for acute primary intracerebral haemorrhage","author":"You","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T03:02:47Z","timestamp":1754449367000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD005951.pub5"}},"subtitle":[],"editor":[{"name":"Cochrane Stroke Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,10,23]]},"references-count":97,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005951.pub5","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,23]]}}}